DIA会员及用户请点击登录

登录

忘记用户 ID? or 忘记密码?

Not a Member?

创建账户并加入。

Novotel Mumbai Juhu Beach

2024 年 09 月 24 日 8:00 上午 - 2024 年 09 月 25 日 6:00 下午

Balraj Sahni Marg, Juhu Beach, Mumbai 400049, India

DIA India Annual Meeting 2024

Confluence of Care: Pharmacovigilance, Clinical Innovation, Regulatory Sciences, and Medical Devices Elevating Patient Safety

Track 3 Session 2: Clinical Evidence for Medical Devices

Session Chair(s)

Ashish  Indani

Ashish Indani

Managing Director, Krishnamugdha Advance ResearchTeck, India

Clinical Evidence for Medical Devices is regarded as one of the most revolutionary aspects of its entire lifecycle, involving numerous stakeholders. Unlike drugs, clinical evidence requirement for medical devices is not straightforward or systematic and is even discretional to some extent. In this session, the expertise of industry speakers will help you comprehend the optimal extent and method for Clinical Evidence of Medical Devices.

Speaker(s)

Debashis  Das

Debashis Das

Medical/Clinical Affairs, Training & Education Leader - APAC, Medtronic, India

How Much And What Clinical Evidence Is Sufficient For Medical Devices?

Srirupa  Das

Srirupa Das

Healthcare Industry Leader, India

Dialogue: General Safety And Performance Requirements Vs. Essential Principles – What Should Be The Focus Of The CER?

Siddharth  Jain

Siddharth Jain

CEO and Medical Device Regulatory Advisor, Symbiorph Clinical Trialogy, India

With Additional Participation Of:

Ashokkumar  Thakkar

Ashokkumar Thakkar

Head of Clinical Research, Meril Life Sciences Pvt. Ltd., India

Contributing Panelist

获得信息并保持参与

不要错失任何机会——请加入我们的邮件列表,了解DIA的观点和事件。